Sponsor Deadline
Posted: 4/18/2022

COVID-19 and Emerging Respiratory Viruses Research Award

For over 115 years, the American Lung Association has focused on driving excellence and innovation through research. Today, we continue to support trailblazing research, novel ideas and innovative approaches with the hope of eliminating lung disease and improving life for those living with lung disease.

Coronavirus infection (coronavirus disease, COVID-19) shows few signs of abating soon. There is an urgent need to better understand the biological and the immediate and long-term clinical implications of the viral infection that leads to the morbidity and mortality seen with COVID-19.

Last spring, the American Lung Association launched a $25 million, three-year initiative to end COVID-19 and defend against future respiratory virus pandemics. This multi-pronged initiative highlights our long-term and ever-deepening commitment to lung health across our three areas of focus: education, advocacy and research. As part of that continued investment, we are launching a second funding cycle and call for proposals to address this critical issue.

Deadline for Letter of Intent: Feb. 18, 2021

Funding Type